In the current study, our group was able to demonstrate that ED-A+ Fn is valuable biomarker also for cardiovascular (extracellular matrix) remodeling by proving that heart failure patients exhibit significantly increased serum levels compared to healthy controls. Here, EDA is linked to heart failure.